[Retracted] Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines

[Retracted] Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines

Following the publication of the above paper, a concerned reader drew to the Editor's attention that Fig. 5 contained apparent anomalies, including unexpectedly similar-looking cells and repeated patternings of the cells in terms of their layout/arrangement within the data panels. After having...

Shranjeno v:

Bibliografske podrobnosti
Main Authors:	Li Wang, Jian Wu, Jianwei Lu, Rong Ma, Dawei Sun, Jinhai Tang
Format:	Retratação/Retirada
Jezik:	angleščina
Izdano:	2021
Online dostop:	https://doi.org/10.3892/mmr.2021.12080 https://www.spandidos-publications.com/10.3892/mmr.2021.12080/download
Oznake:	Označite Brez oznak, prvi označite!

Podobne knjige/članki

Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines
od: Li Wang, et al.
Izdano: (2014)

Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines
od: WANG, LI, et al.
Izdano: (2015)

Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines
od: Wang, Li, et al.
Izdano: (2021)

Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway
od: Liu, Huayuan, et al.
Izdano: (2021)

Diterpenoid tanshinones inhibit gastric cancer angiogenesis through the PI3K/Akt/mTOR signaling pathway
od: Jie-ru Yu, et al.
Izdano: (2024)

Tanshinone IIa Induces Autophagy and Apoptosis via PI3K/Akt/mTOR Axis in Acute Promyelocytic Leukemia NB4 Cells
od: Pan, Yiming, et al.
Izdano: (2021)

Retraction Note to: Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours
od: Xu, Fei, et al.
Izdano: (2021)

RETRACTED ARTICLE: Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours
od: Fei Xu, et al.
Izdano: (2020)

PI3K/AKT/mTOR Pathway in Angiogenesis
od: Karar, Jayashree, et al.
Izdano: (2011)

PI3K/AKT/mTOR Pathway in Angiogenesis
od: Jayashree Karar, et al.
Izdano: (2011)

Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB-152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway
od: Teng, Zhi, et al.
Izdano: (2020)

Suppression of PI3K/Akt/mTOR/c-Myc/mtp53 Positive Feedback Loop Induces Cell Cycle Arrest by Dual PI3K/mTOR Inhibitor PQR309 in Endometrial Cancer Cell Lines
od: Hsin, I-Lun, et al.
Izdano: (2021)

Targeting PI3K/Akt/mTOR Signaling in Cancer
od: Porta, Camillo, et al.
Izdano: (2014)

Targeting PI3K/Akt/mTOR Signaling in Cancer
od: Camillo Porta, et al.
Izdano: (2014)

Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway
od: Zhou, Jin, et al.
Izdano: (2019)

Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway
od: Jin Zhou, et al.
Izdano: (2019)

Tanshinone IIA decreases the protein expression of EGFR, and IGFR blocking the PI3K/Akt/mTOR pathway in gastric carcinoma AGS cells both in vitro and in vivo
od: Chin‐Cheng Su, et al.
Izdano: (2016)

Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors
od: Philip, Charles-André, et al.
Izdano: (2017)

The Gene Expression Status of the PI3K/AKT/mTOR Pathway in Gastric Cancer Tissues and Cell Lines
od: Riquelme, Ismael, et al.
Izdano: (2016)

Molecular determinants of response to PI3K/akt/mTOR and KRAS pathways inhibitors in NSCLC cell lines
od: Iezzi, Alice, et al.
Izdano: (2020)

The Gene Expression Status of the PI3K/AKT/mTOR Pathway in Gastric Cancer Tissues and Cell Lines
od: Ismael Riquelme, et al.
Izdano: (2016)

Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors
od: Charles-André Philip, et al.
Izdano: (2017)

EGFR Activation Leads to Cell Death Independent of PI3K/AKT/mTOR in an AD293 Cell Line
od: Treda, Cezary, et al.
Izdano: (2016)

Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas
od: Bhatt, Aadra P., et al.
Izdano: (2010)

Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas
od: Aadra P. Bhatt, et al.
Izdano: (2010)

The PI3K-Akt-mTOR pathway regulates Aβ oligomer induced neuronal cell cycle events
od: Bhaskar, Kiran, et al.
Izdano: (2009)

The PI3K-Akt-mTOR pathway regulates Aβ oligomer induced neuronal cell cycle events
od: Kiran Bhaskar, et al.
Izdano: (2009)

AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV
od: Bhatt, Aadra P., et al.
Izdano: (2013)

Inhibition of PI3K/Akt/mTOR Signaling by Natural Products
od: Huang, Shile
Izdano: (2013)

Targeting the PI3K/Akt/mTOR Pathway – Beyond Rapalogs
od: Markman, Ben, et al.
Izdano: (2010)

Targeting the PI3K-AKT-mTOR signaling network in cancer
od: Khan, Khurum H., et al.
Izdano: (2013)

Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
od: Fransecky, Lars, et al.
Izdano: (2015)

Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma
od: Westin, Jason R.
Izdano: (2014)

The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma
od: Matsuoka, Tasuku, et al.
Izdano: (2014)

Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis
od: Barra, Fabio, et al.
Izdano: (2018)

PI3K/AKT/mTOR pathway in pulmonary carcinoid tumours
od: Zhang, Zixuan, et al.
Izdano: (2017)

Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors
od: LoRusso, Patricia Mucci
Izdano: (2016)

Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
od: Sun, Eun Jin, et al.
Izdano: (2021)

PI3K/AKT/mTOR pathway in tumor progression of oligodendrogliomas
od: Lisi, Lucia
Izdano: (2020)

Roles of PI3K/AKT/mTOR Axis in Arteriovenous Fistula
od: Ratti, Stefano, et al.
Izdano: (2022)